|
|
||||||||||||||
|
|
|||||||||||||||
REVIEW |
1 Department of Chemical Pathology, Bishop Auckland General Hospital, Cockton Hill Road, Bishop Auckland, County Durham, UK
2 Sowerby Centre for Health Informatics, Bede House, All Saints Business Centre, Newcastle upon Tyne, UK
3 Department of Oncology, Nottingham City Hospital, Nottingham, UK
4 Department of Obstetrics and Gynaecology, St Helier Hospital, Carshalton, Surrey, UK
5 Health Protection Agency Primary Care Unit, Department of Microbiology, Gloucester Royal Hospital, Great Western Road, Gloucester, UK
6 Department of Clinical Biochemistry, University Hospital Aintree, Longmoor Lane, Liverpool, UK
7 Department of Clinical Chemistry, Queens Hospital, Belvedere Road, Burton on Trent, Staffordshire, UK
8 Department of Haematology, Sunderland Royal Hospital, Kayll Road, Sunderland, UK
Correspondence to:
W S A Smellie
Department of Chemical Pathology, Bishop Auckland General Hospital, Cockton Hill Road, Bishop Auckland, County Durham DL14 6AD, UK; info{at}smellie.com
ABSTRACT
This fourth best practice review examines four series of common primary care questions in laboratory medicine are examined in this review: (1) safety monitoring for three common drugs; (2) use of prostate-specific antigen; (3) investigation of vaginal discharge; and (4) investigation of subfertility. The review is presented in questionanswer format, referenced for each question series. The recommendations represent a precis of the guidance found using a standardised literature search of national and international guidance notes, consensus statements, health policy documents and evidence-based medicine reviews, supplemented by Medline Embase searches to identify relevant primary research documents. They are not standards but form a guide to be set in the clinical context. Most of them are consensus based rather than evidence based. They will be updated periodically to take account of new information.
Abbreviations: BNF, British National Formulary; DRE, digital rectal examination; FSH, follicular stimulating hormone; GMS, General Medical Services; HVS, high vaginal swab; NHS, National Health Service; NICE, National Institute of Health and Clinical Excellence; PCOS, polycystic ovary syndrome; PID, pelvic inflammatory disease; PSA, prostate-specific antigen; SFA, seminal fluid analysis; STI, sexually transmitted infection; TFT, thyroid function test; TSH, thyroid-stimulating hormone
This article has been cited by other articles:
![]() |
W S A Smellie, N Shaw, R Bowley, M F Stewart, A M Kelly, P J Twomey, P R Chadwick, J B Houghton, J P Ng, and A J McCulloch Best practice in primary care pathology: review 10 J. Clin. Pathol., November 1, 2007; 60(11): 1195 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
W S A Smellie, N Shaw, R Bowlees, A Taylor, R Howell-Jones, and C A M McNulty Best practice in primary care pathology: review 9 J. Clin. Pathol., September 1, 2007; 60(9): 966 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Fleming The state of play in the battle against antimicrobial resistance: a general practitioner perspective J. Antimicrob. Chemother., August 1, 2007; 60(suppl_1): i49 - i52. [Abstract] [Full Text] [PDF] |
||||
![]() |
W S A Smellie, K K Hampton, R Bowlees, S C Martin, N Shaw, J Hoffman, J P Ng, S M Mackenzie, and C van Heyningen Best practice in primary care pathology: review 8 J. Clin. Pathol., July 1, 2007; 60(7): 740 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
W S A Smellie, J Forth, S R S Smart, M J Galloway, W Irving, D Bareford, P O Collinson, K G Kerr, G Summerfield, P J Carey, et al. Best practice in primary care pathology: review 7 J. Clin. Pathol., May 1, 2007; 60(5): 458 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
W S A Smellie, J Forth, J J Coleman, W Irvine, P C Dore, G Handley, D G Williams, P J Galloway, K G Kerr, R Herriot, et al. Best practice in primary care pathology: review 6 J. Clin. Pathol., March 1, 2007; 60(3): 225 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
W S. A Smellie and J. J Coleman Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin BMJ, February 10, 2007; 334(7588): 312 - 315. [Full Text] [PDF] |
||||
![]() |
W S. A Smellie Cases in primary care laboratory medicine: testing pitfalls and summary of guidance on sex hormone testing BMJ, January 13, 2007; 334(7584): 91 - 94. [Full Text] [PDF] |
||||
![]() |
W S A Smellie, J Forth, S Ryder, M J Galloway, A C Wood, and I D Watson Best practice in primary care pathology: review 5 J. Clin. Pathol., December 1, 2006; 59(12): 1229 - 1237. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |